125 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
. There are certain exceptions for trading in the United Kingdom through independent agents, such as some brokers and investment managers.
All … ended December 31, 2023 have been audited by Ernst & Young LLP (PCAOB ID: 01438), independent registered public accounting firm, as set forth
S-3ASR
EX-5.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
in the Secretary’s Certificate and we have not undertaken any independent investigation or verification of the matters referred to in the Secretary’s
S-3ASR
EX-23.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts
10-K
2023 FY
EX-23.1
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration
10-K
2023 FY
EX-97.1
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
of independent directors, a majority of the independent directors serving on the Board, has made a determination that recoupment would be impracticable
10-K
EX-10.12
8vjo0pkslstm9z3
21 Mar 24
Annual report
4:55pm
10-K
3loyyf
21 Mar 24
Annual report
4:55pm
8-K
5i2j gktlke59rnd
21 Mar 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
8-K/A
EX-99.1
4od3qbim r4
15 Mar 24
Results of Operations and Financial Condition
4:21pm
8-K
EX-99.1
6o2c5lm6qn5pq
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.2
yg5evxzzrd5peum
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.1
kdb9vuo2m 4fh
13 Feb 24
Regulation FD Disclosure
4:06pm
424B5
j5cmsszun786ot0 4o
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
rj34jfa
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-5.1
fnoe27xg4i
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
8aed5jsd sjxxl0a
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
m4kh9yjex 0x5e10dl
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.3
nq2xl 8tyc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
cd2o03oczl
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-5.1
bybkkhdd
7 Feb 24
Automatic shelf registration
10:00pm